Evidence map›Paper›PMID 36291823›Full record

ArticleCancers2022

Is There a Role for Exercise When Treating Patients with Cancer with Immune Checkpoint Inhibitors? A Scoping Review.

Jasmine Handford, Miaoqi Chen, Ridesh Rai, Charlotte L Moss, Deborah Enting, Nicola Peat, Sophia N Karagiannis, Mieke Van Hemelrijck, Beth Russell

Registry-linked trialAbstract readScoping Review
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06152926 (Physical Activity and Exercise in Urological Cancers Receiving Immune Check Point Inhibitor Treatment - a Qualitative Study Exploring Patient Perspectives and Experiences), which is not on this map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06152926 unknown statusnot on this mapstarted 2023, after this paper: background citation

Physical Activity and Exercise in Urological Cancers Receiving Immune Check Point Inhibitor Treatment - a Qualitative Study Exploring Patient Perspectives and Experiences

TypeobservationalSponsorGuy's and St Thomas' NHS Foundation TrustRan2023 to 2024Enrolled12ConditionsCancerArmsPhysical Activity and Exercise in Cancer Immunotherapy Treatment - Exploratory study of experiences and perceptions
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Co-Designing Lung Cancer Rehabilitation Services for People Treated With Immunotherapy.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  5. Review
  6. Article
  7. A Retrospective Cohort Study of Physical Activity and Survival in Patients Treated with Immune Checkpoint Inhibitors.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jasmine HandfordTranslational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 9RT, UK.ORCID 0000-0002-5341-0949
Miaoqi ChenTranslational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 9RT, UK.
Ridesh RaiTranslational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 9RT, UK.
Charlotte L MossTranslational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 9RT, UK.
Deborah EntingGuy's and St Thomas' NHS Foundation Trust, London SE1 9RT, UK.
Nicola PeatGuy's and St Thomas' NHS Foundation Trust, London SE1 9RT, UK.
Sophia N KaragiannisSt John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London, London SE1 9RT, UK.ORCID 0000-0002-4100-7810
Mieke Van HemelrijckTranslational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 9RT, UK.
Beth RussellTranslational Oncology and Urology Research (TOUR), School of Cancer and Pharmaceutical Sciences, King's College London, London SE1 9RT, UK.ORCID 0000-0001-5640-8425

Funding

Medical Research Council MR/L023091/1
6 · The paper itself

Abstract

The impact of using exercise as a non-pharmacological intervention in patients with cancer receiving immune checkpoint inhibitors (ICIs) is not well known. Our objective was to determine the extent of, and identify gaps within, available literature addressing the effect of exercise on (a) oncological outcomes and (b) quality of life (QoL) in patients with cancer receiving ICIs, and (c) the underlying biological mechanisms for such effects. We conducted searches across EMBASE, APA PsycInfo and Ovid MEDLINE(R). Studies were eligible if they addressed at least one aspect of the objective and were available in the English language. Results were synthesised using a narrative approach and subsequently discussed with multidisciplinary stakeholders. As of the final search on 5 April 2022, 11 eligible studies were identified, of which 8 were preclinical and 3 were clinical. Clinical studies only focused on QoL-related outcomes. When studies were grouped by whether they addressed oncological outcomes (n = 7), QoL (n = 5) or biological mechanisms (n = 7), they were found to be heterogeneous in methodology and findings. Additional evidence, particularly in the clinical setting, is required before robust recommendations about whether, and how, to include exercise alongside ICI treatment can be made.

Indexed as

cancerexerciseimmune checkpointphysical activityquality of lifescoping review

Identifiers

PMID36291823
PMCPMC9599872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.